Order of the General Court (Fifth Chamber) of 12 October 2016 —
Lysoform Dr. Hans Rosemann and Others v ECHA

(Case T‑543/15)

(Actions for annulment — Inclusion as supplier of an active substance on the list provided for in Article 95 of Regulation (EU) No 528/2012 — No direct concern — Inadmissibility)

1.                     Actions for annulment — Natural or legal persons — Measures of direct and individual concern to them — Whether directly concerned — Criteria — Decision of the European Chemicals Agency (ECHA) concerning registration of a company as supplier of an active substance on the list referred to in Article 95(1), first subpara., of Regulation No 528/2012 — Action brought by companies appearing on that list as suppliers of the said substance — Inadmissibility (Art. 263, fourth para., TFEU; European Parliament and Council Regulation No 528/2012, Art. 95(1), first subpara., and (2)) (see paras 29, 33, 36, 37)

2.                     Actions for annulment — Natural or legal persons — Meaning of ‘regulatory act’ in Article 263, fourth paragraph, TFEU — Any act of general scope other than legislative acts — Decision of the European Chemicals Agency (ECHA) concerning registration of a company as supplier of an active substance on the list referred to in Article 95(1), first subpara., of Regulation No 528/2012 — Not included (Art. 263, fourth para., TFEU; European Parliament and Council Regulation No 528/2012, Art. 95(1), first subpara., and (2)) (see paras 78-80)

Re:

ACTION pursuant to Article 263 TFEU for annulment of the decision of ECHA of 17 June 2015 concerning the inclusion of the company Oxea GmbH, established in Germany, as supplier of an active substance on the list referred to in Article 95(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ 2012 L 167, p. 1).

Operative part

1. The action is dismissed as inadmissible.

2. There is no longer any need to adjudicate on the applications to intervene of Oxea GmbH and BASF SE.

3. Lysoform Dr. Hans Rosemann GmbH, Ecolab Deutschland GmbH, Schülke & Mayr GmbH and Diversey Europe Operations BV shall bear their own costs and pay those incurred by the European Chemicals Agency (ECHA) except for those relating to the applications for leave to intervene.

4. Lysoform Dr. Hans Rosemann, Ecolab Deutschland, Schülke & Mayr, Diversey Europe Operations, ECHA, Oxea and BASF shall each bear its own costs relating to the applications for leave to intervene.